PL1898961T3 - Sposób indywidualizacji terapii lewodopą i karbidopą na podstawie badania wydychanego powietrza - Google Patents

Sposób indywidualizacji terapii lewodopą i karbidopą na podstawie badania wydychanego powietrza

Info

Publication number
PL1898961T3
PL1898961T3 PL06780854T PL06780854T PL1898961T3 PL 1898961 T3 PL1898961 T3 PL 1898961T3 PL 06780854 T PL06780854 T PL 06780854T PL 06780854 T PL06780854 T PL 06780854T PL 1898961 T3 PL1898961 T3 PL 1898961T3
Authority
PL
Poland
Prior art keywords
individualization
levodopa
examination
exhaled air
therapy based
Prior art date
Application number
PL06780854T
Other languages
English (en)
Inventor
Anil S Modak
Yasuhisa Kurogi
Original Assignee
Otsuka America Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka America Pharmaceutical Inc filed Critical Otsuka America Pharmaceutical Inc
Publication of PL1898961T3 publication Critical patent/PL1898961T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Atmospheric Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL06780854T 2005-06-30 2006-06-30 Sposób indywidualizacji terapii lewodopą i karbidopą na podstawie badania wydychanego powietrza PL1898961T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69550305P 2005-06-30 2005-06-30
PCT/JP2006/313529 WO2007004715A1 (en) 2005-06-30 2006-06-30 Method and composition to individualize levodopa/carbidopa therapy using a breath test
EP06780854.3A EP1898961B1 (en) 2005-06-30 2006-06-30 Method to individualize levodopa/carbidopa therapy using a breath test

Publications (1)

Publication Number Publication Date
PL1898961T3 true PL1898961T3 (pl) 2014-07-31

Family

ID=37604572

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06780854T PL1898961T3 (pl) 2005-06-30 2006-06-30 Sposób indywidualizacji terapii lewodopą i karbidopą na podstawie badania wydychanego powietrza

Country Status (10)

Country Link
US (1) US20070003481A1 (pl)
EP (2) EP2921181A1 (pl)
DK (1) DK1898961T3 (pl)
ES (1) ES2450690T3 (pl)
HK (1) HK1215377A1 (pl)
PL (1) PL1898961T3 (pl)
PT (1) PT1898961E (pl)
SI (1) SI1898961T1 (pl)
TW (1) TW200744646A (pl)
WO (1) WO2007004715A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021207634A1 (en) * 2020-04-10 2021-10-14 Senda Biosciences, Inc. Biomarkers related to parkinson's disease and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0781145B1 (en) * 1995-08-08 2003-07-16 Otsuka Pharmaceutical Co., Ltd. Diagnostic compositions and their use for the detection of central nervous system abnormalities
CA2249173C (en) * 1997-10-06 2008-12-16 Tokyo Gas Co., Ltd. Diagnostic agent for liver function
MXPA04008180A (es) * 2002-02-21 2005-05-16 Tokyo Gas Co Ltd Reactivo de diagnostico para evaluacion de efecto farmacologico de medicina, y metodo y reactivo para seleccionar agentes farmaceuticos que comprenden enzima, inhibidor de enzima o ligando receptor y/o promedicamentos del mismo para uno que tiene alt

Also Published As

Publication number Publication date
DK1898961T3 (en) 2014-03-10
US20070003481A1 (en) 2007-01-04
EP2921181A1 (en) 2015-09-23
EP1898961A4 (en) 2011-05-18
SI1898961T1 (sl) 2014-08-29
EP1898961A1 (en) 2008-03-19
HK1215377A1 (en) 2016-08-26
ES2450690T3 (es) 2014-03-25
TW200744646A (en) 2007-12-16
PT1898961E (pt) 2014-03-06
EP1898961B1 (en) 2014-02-26
WO2007004715A1 (en) 2007-01-11

Similar Documents

Publication Publication Date Title
IL186684A0 (en) N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stress
CY2018013I1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
EP1885281A4 (en) STENT DEVICES FOR TREATMENT ABOUT BODY LIQUES AND USE METHOD
EP1988961A4 (en) ARRANGEMENT FOR FIXING A MEDICAL TUBE AND APPLICATION METHOD
NO20076206L (no) Kombinasjon av PDE4 inhibitor romflumilast og et tetrahydrobioterin-derivativ
ITMI20020078A0 (it) Dispositivo utilizzabile nel tratamento di affezzioni delle vie respiratorie
DK1889065T3 (da) Metoder til diagnostisering og behandling af sygdomme med en autoimmun- og/eller inflammationskomponent
NO20081842L (no) Fremgangsmåter og sammensetninger for anvendelse ved behandling av pasienter med autoantistoff-positive sykdommer
UA94221C2 (en) Lipocalin protein
NL1020288A1 (nl) Samenstel omvattende een stabilisator en een in of rondom een door lichaamsweefsel, omgeven doorgang te positioneren instrument.
IL179525A0 (en) Treatment with gemcitabine and an egfr-inhibitor
FI20080423L (fi) Biologisten komponenttien rikastusyksikkö ja rikastusmenetelmä
DK2609855T3 (da) Balanceret fysiologisk overvågnings- og behandlingssystem
EP1933040A4 (en) TURBO FAN AND AIR CONDITIONING
DE602006005867D1 (de) Lichtemittierende Vorrichtung und deren Herstellung
DK1700598T3 (da) Antiproliferativ kombinationsterapi med satraplatin eller JM118 og docetaxel
DE602006000349D1 (de) Medizinisches Instrument mit medizinischer Behandlungselektrode
DE602006004713D1 (de) Trifluormethylbenzamidderivate und therapeutische verwendungen dafür
EP1781685A4 (en) THERAPEUTIC AND DIAGNOSTIC AGENTS
EP2101736A4 (en) HOMOGENEOUS PULP AND GEL PREPARATIONS
EP1864783A4 (en) BONDED BODY AND METHOD OF BONDING
DE602006018387D1 (de) Thermofixierbare Lösungszusammensetzung und Prepreg
PL1898961T3 (pl) Sposób indywidualizacji terapii lewodopą i karbidopą na podstawie badania wydychanego powietrza
FI20021617A7 (fi) Diagnostisia ja terapeuttisia menetelmiä
FR2937415B1 (fr) Instrument combine de secours et procede de calibration de l'instrument combine de secours